3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry

Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen PT, Janda A, Rech J, Schuetz C, Kallinich T, Weller-Heinemann F, Horneff G, Foeldvari I, Meier F, Borte M, Krickau T, Weber-Arden J, Blank N (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: WILEY

City/Town: HOBOKEN

Pages Range: 1613-1614

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Kuemmerle-Deschner, J.B., Kortus-Goetze, B., Oommen, P.T., Janda, A., Rech, J., Schuetz, C.,... Blank, N. (2022). 3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry. In ARTHRITIS & RHEUMATOLOGY (pp. 1613-1614). HOBOKEN: WILEY.

MLA:

Kuemmerle-Deschner, Jasmin B., et al. "3-years Safety and Efficacy Outcomes of Canakinumab Treatment in Cryopyrin-associated Periodic Syndromes (CAPS) - Data from the RELIANCE Registry." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2022. 1613-1614.

BibTeX: Download